Menu Menu

News

Featured
COVID-19 Research Pipeline

84,240

Registered/ Published

3,408

Registered

407

Published

5,201

Registered
As at 16 September 2021
FILTERED BY > latest_guidance Clear filter

Taskforce makes conditional recommendation for use of sotrovimab 

26 August, 2021
The National COVID-19 Clinical Evidence Taskforce today published three recommendations on the use of sotrovimab for the treatment of COVID-19 in adults who do not require oxygen and who have risk factors for disease progression. These are the first recommendations from the Taskforce to use a drug to treat patients with mild illness.  The Taskforce updated the sotrovimab recommendation after...
Media Release

Coverage: Understanding evidence

17 August, 2021
Science reporter for the The Age and Sydney Morning Herald, Liam Mannix explains the critical role of gold standard evidence and highlights the role of Cochrane and the...
News

Communique # 48

5 August, 2021
WEEK IN REVIEW Taskforce amends remarks for Tocilizumab in response to critical shortage This week the Taskforce was alerted by the Therapeutic Goods Administration (TGA) to a global tocilizumab shortage...
Communique

Taskforce amends remarks for Tocilizumab in response to critical shortage

5 August, 2021
This week the Taskforce was alerted by the Therapeutic Goods Administration (TGA) to a global tocilizumab shortage for both COVID-19 treatment use and other indications. To help support...
News

Guidelines update, v41.2

22 July, 2021
Version 41.2 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of two new studies on disease-modifying treatments: Canakinumab NEW – one...
News

EXPLAINER: What happens if I test positive to COVID-19?

19 July, 2021
With the recent COVID-19 outbreak in NSW and Victoria, it’s timely to revisit what happens if you test positive with COVID-19.  With so much media commentary and coverage...
Explainer

Guidelines update, v41.1

15 July, 2021
Version 41.1 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of six new studies on disease-modifying treatments. Convalescent plasma - two...
News

Communique # 47

1 July, 2021
WEEK IN REVIEW Updates to the Living Treatment Guideline New recommendations Three new recommendations for the use of Casirivimab plus imdevimab (REGEN-COV) The Disease-Modifying Treatment and Chemoprophylaxis Panel...
Communique

Guidelines update, v40.3

25 June, 2021
Version 40.3 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of several new studies on disease-modifying treatments as well as an...
News

Guidelines update, v40.2

17 June, 2021
Version 40.2 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of three new studies on disease-modifying treatments. In addition, the treatment...
News

Taskforce publishes guidance to help healthcare workers and organisations make decisions about PPE during the COVID-19 pandemic

10 June, 2021
Following today’s publication of the Infection Control Expert Group (ICEG)’s Guidance on the use of personal protective equipment (PPE) for health care workers in the context of COVID-19,...
News

Communique # 46

10 June, 2021
WEEK IN REVIEW Taskforce publishes guidance to help healthcare workers and organisations make decisions about PPE during the COVID-19 pandemic Following today’s publication of the Infection Control Expert...
Communique

Communique # 45

3 June, 2021
Dear colleagues, On behalf of our 32 Taskforce members, we acknowledge our Victorian colleagues during another challenging and anxious time. Look after yourselves and each other, and we all hope an easing of...
Communique

Head to ATAGI or NCIRS for vaccine advice

28 May, 2021
The Taskforce is responsible for treatment guidelines for the management of COVID-19. The body responsible for vaccine advice is the Australian Technical Advisory Group on Immunisation (ATAGI). For...
News

Guidelines update, v39.1

28 May, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week includes the following change to the evidence summary section for:   REGN-COV2 The...
News

Communique # 44

24 May, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE New recommendations Baricitinib upgraded to a conditional recommendation The Disease-Modifying Treatment and Chemoprophylaxis Panel has reviewed the latest evidence for...
Communique

Guidelines update, v38.3

13 May, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include the following changes to the evidence summary sections for:   Convalescent plasma...
News

Communique # 43

10 May, 2021
WEEK IN REVIEW Taskforce reaches consensus on first IPC recommendations On Monday 03 May, the Taskforce provided the Infection Control Expert Group (ICEG) with the final draft of the...
Communique

Steve McGloughlin: A team approach in an intensive year

7 May, 2021
When the COVID-19 pandemic took hold in early 2020, the Intensive Care Unit (ICU) team at The Alfred hospital in Melbourne set itself the goal that no one...
News

WEBINAR – Murray PHN hosts ‘Long COVID Symptoms: Management of long term effects’

6 May, 2021
International event hosted by Dr Norman Swan LONG COVID SYMPTOMS: Management of long term effects – what is known so far? Taskforce Senior Evidence Officer and Primary Care...
News

🎥 WEBINAR: Living Evidence, COVID-19 and consumers?

4 May, 2021
Learn how the Taskforce develops living guideline recommendations and the role of consumers If you missed the recent webinar hosted by Consumers Health Forum of Australia, you can...
Video

Guidelines update, v38.1

29 April, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include the following changes to the evidence summary sections for:   - Lopinavir-ritonavir...
News

Communique # 42

22 April, 2021
Message from the Chair and Executive Director Dear Colleagues We’ve just passed 12-months since the first publication of the Australian clinical guidelines for the care of people with COVID-19....
Communique

Webinar: Living Evidence and consumers

22 April, 2021
Are you interested in developing a better understanding of how clinical guidelines can be kept up-to-date with the latest evidence as new research emerges? The Taskforce is proud...
News

Guidelines update, v37.1

15 April, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include the following changes to the evidence summary sections for:   - Corticosteroids...
News

Communique # 41

1 April, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE Convalescent plasma recommendation changed to 'do not use' The Taskforce Disease Modifying and Chemoprophylaxis Panel and the Guidelines Leadership Group have incorporated...
Communique

Guidelines update, v36.1

25 March, 2021
Update to the Australian guidelines for the clinical care of people with COVID-19 this week includes:   Bromhexine hydrochloride - additional study has been added to the summary...
News

Communique # 40

18 March, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE New recommendation for tocilizumab in children or adolescents Further to the Taskforce's recent recommendation for the conditional use of tocilizumab for adults (25...
Communique

Taskforce continuing to recruit HCWs for IPC consultation

18 March, 2021
The Taskforce will soon be conducting a series of consultations with frontline healthcare workers to provide feedback on the implementability of draft infection prevention and control (IPC) recommendations....
News

Guidelines update, v35.2

11 March, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include:   Tocilizumab - The reference for one included study (Wang et al.) was...
News

Women who lead: Sutapa Mukherjee and her journey to the Taskforce

8 March, 2021
As the female co-chair of the Taskforce Guidelines Leadership Group, the contribution of Associate Professor Sutapa Mukherjee in the fight against COVID-19 is reason enough to be recognised...
News

Guidelines update, v35.1

4 March, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include: Tocilizumab - The references for REMAP-CAP and COVACTA (Rosas et al.) trials have...
News

WANTED: Frontline healthcare workers for IPC recommendations consultation

3 March, 2021
The Taskforce is currently recruiting frontline healthcare workers in Australia to volunteer to participate in a series of consultations to provide feedback on the implementability of draft IPC...
News

Communique # 39

25 February, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE Tocilizumab upgraded to conditional recommendation The Taskforce Disease Modifying Treatment and Chemoprophylaxis Panel and the Guidelines Leadership Group have incorporated...
Communique

Seeking consumers and carers with lived experience of COVID-19

24 February, 2021
Share your lived experiences of COVID-19 and contribute to the national guidelines The Taskforce welcomes people who have been affected by COVID-19 to join the Consumer Panel.  The...
News

Guidelines update, version 34.1

18 February, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include:   Dutasteride - preprint publication status has been removed from the summary information...
News

RECOVERY Trial publishes tocilizumab results

12 February, 2021
The Taskforce notes the publication of results of the tocilizumab arm of the RECOVERY trial in medRxiv Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results...
News

Communique # 38

11 February, 2021
Message from the Taskforce Chair Dear colleagues As we enter the second year of the COVID-19 pandemic it is timely to acknowledge the important role of the Taskforce’s...
Communique

Guidelines update, version 33.1

5 February, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include: Additional study (Mohan et al.) added to the summary information for Ivermectin recommendation: We...
News

Communique # 37

29 January, 2021
Following a well-earned break, the Taskforce team has now returned to full capacity. Global evidence surveillance continued throughout January, with six clinical panel meetings held since January 11....
Communique

Taskforce recommendation for tocilizumab unchanged

29 January, 2021
The Taskforce Disease Modifying Treatments and Chemoprophylaxis Panel and the Guidelines Leadership Group have incorporated the results of the tocilizumab arm of the REMAP-CAP trial (published as a pre-print on January 7,...
News

Statement on joint media release from the REMAP-CAP, ACTIV-4 and ATTACC trials regarding anticoagulation

24 December, 2020
The Taskforce acknowledges the publication of a joint media release from the REMAP-CAP, ACTIV-4 and ATTACC trial teams on December 22nd, 2020. The investigators have reported that among...
News

Taskforce recommendations for remdesivir unchanged following detailed analysis of disease severity subgroups

18 December, 2020
The Taskforce has completed a comprehensive review to assess the credibility of disease severity subgroups used in its recommendations on remdesivir. This was initiated following the World Health Organisation...
News

2020 in review

18 December, 2020
This week marks our 36th weekly guidelines update which now incorporates 118 living guideline recommendations, 10 living clinical flowcharts, and covers over 100 clinical questions. The Taskforce website has been viewed...
News

Weekly Communique # 36

17 December, 2020
Dear colleagues, It’s hard to fully comprehend a year like 2020. The pandemic has affected us all and no doubt its impact will continue and reverberate for some...
Communique

Weekly Communique # 35

10 December, 2020
WEEK IN REVIEW Updates to the living guideline New recommendations published this week cover: Combined metabolic cofactor supplementation (CMCS) Vitamin D analogues (formerly just calcifediol, now also includes cholecalciferol) Updated...
Communique

Greater than the sum of its parts: how The Ian Potter Foundation’s early and generous support helped the Taskforce deliver in 2020

9 December, 2020
Looking back over what’s universally recognised as a most extraordinary year, the National COVID-19 Clinical Evidence Taskforce represents something greater than the sum of its parts. On one...
News

Weekly Communique # 34

3 December, 2020
WEEK IN REVIEW Updates to the living guideline New recommendations published this week cover: Dutasteride Oestrogen-containing therapies (including menopause hormone therapies (MHT) and contraceptives). These recommendations were developed by the...
Communique

New expert panel to bring latest evidence and clinical experience together to prevent COVID-19 transmission in healthcare settings

30 November, 2020
The National COVID-19 Clinical Evidence Taskforce has today announced the membership of its new expert panel for infection prevention and control (IPC), which will be jointly chaired by...
News

A year like no other: Professor Carol Hodgson takes a look back at the collaboration, collegiality and contributions inspired by COVID-19

28 November, 2020
Professor Carol Hodgson knows first-hand the challenges facing frontline health workers, researchers and guideline developers in the time of COVID. A few months into 2020, she was already...
News

Weekly Communique # 33

26 November, 2020
WEEK IN REVIEW Updates to the living guideline Three new recommendations have been published this week covering: Bamlanivimab Fluvoxamine Intravenous immunoglobulin VTE prophylaxis for children and adolescents Further details are...
Communique

Weekly Communique # 32

19 November, 2020
WEEK IN REVIEW BREAKING NEWS: Australian-led REMAP-CAP Trial reports benefit of tocilizumab for critically ill patients with COVID-19. The REMAP-CAP investigators led by Prof Steve Webb, Monash University, have this...
Communique

Help shape the guidelines

19 November, 2020
The second Taskforce impact survey was launched today. We are calling on Australian healthcare practitioners to participate in a brief 5-minute survey to help us understand how the...
News

Weekly Communique # 31

12 November, 2020
WEEK IN REVIEW IPC Panel EOI for paediatric and clinical engineering expertise The Taskforce is calling for Expressions of Interest from suitably qualified individuals with paediatric or clinical...
Communique

Care and comfort in the time of COVID: Natasha Smallwood takes a holistic approach to health

11 November, 2020
‘COVID is one of those illnesses that speaks to how much we need a holistic approach to care and comfort,’ says Associate Professor Natasha Smallwood, Deputy Chair of...
News

Julian Elliott on ANZICS ‘Meet the Experts’ podcast

10 November, 2020
This week Taskforce Executive Director, A/Prof Julian Elliott, was interviewed by Dr Swapnil Pawar on ANZICS Meet the Experts podcast to discuss the processes and challenges involved in forming the...
News

Weekly Communique # 30

5 November, 2020
WEEK IN REVIEW Bromhexine hydrochloride added to list of 'only in clinical trials' The Disease-Modifying Treatment and Chemoprophylaxis Panel has reviewed two new trial results for bromhexine hydrochloride (commonly...
Communique

ANZJOG publishes Taskforce paper

2 November, 2020
Led by A/Prof Joshua Vogel, the Australian and New Zealand Journal of Obstetrics and Gynaecology (ANZJOG) has published an early access version of a Taskforce paper on the Clinical...
News

Weekly Communique # 29

29 October, 2020
WEEK IN REVIEW Updates to the living guideline this week New recommendations Three new recommendations have been published covering: Triazavirin Other immunomodulatory agents (PIMS-TS) Aspirin and antithrombotic agents...
Communique

IPC Panel Co-Chairs announced

29 October, 2020
The Taskforce and the Infection Control Expert Group (ICEG) today announced the appointments of Dr Phillipa Hore and A/Prof John Ferguson as Co-Chairs for the new Infection Prevention...
News

Weekly Communique # 28

22 October, 2020
WEEK IN REVIEW SAVING LIVES SAFELY: New CPR flowcharts published today The Taskforce, in partnership with the Infection Control Expert Group (ICEG), has published new clinical flowcharts to guide clinicians...
Communique

Saving lives safely: Adj Clin Prof Simon Craig on adult CPR in healthcare settings during COVID-19.

22 October, 2020
The COVID-19 pandemic has raised significant concerns about healthcare provider safety. In particular, clinicians have had to grapple with what is safe, or not safe to do in...
Video

Saving lives safely: Prof Peter Morley on Basic Life Support in the community during COVID-19.

22 October, 2020
Emerging data suggests that survival rates for out-of-hospital cardiac arrest have fallen during the COVID-19 pandemic, and this may be because first responders are delaying commence of CPR...
Video

Saving lives safely during COVID-19: CPR flowcharts explained

22 October, 2020
Why were the flowcharts developed? The Taskforce received feedback from hospital and community representatives citing a hesitation to commence resuscitation of people in cardiac arrest during the COVID-19...
Explainer

Saving lives safely: Taskforce issues guidance on CPR during the pandemic

22 October, 2020
Healthcare workers and trained first aid responders are being urged not to delay commencing cardiopulmonary resuscitation (CPR) because of the COVID-19 pandemic. The National COVID-19 Clinical Evidence Taskforce,...
Media Release

Weekly Communique # 27

15 October, 2020
WEEK IN REVIEW New PIMS-TS recommendations The Taskforce has made two new consensus recommendations for the management of children with suspected or confirmed Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2...
Communique

Weekly Communique # 26

8 October, 2020
With our evidence team and panels taking a much-needed break, a smaller edition today with no new recommendations or updates to the guidelines and flowcharts this week. Our next update will be next Thursday,...
Communique

COVERAGE: A/Prof Julian Elliott on Trump treatment

7 October, 2020
Our Executive Director, A/Prof Julian Elliott spoke with Liam Mannix from The Age and Sydney Morning Herald about President Trump's treatment for COVID-19.      
News

Weekly Communique # 25

1 October, 2020
WEEK IN REVIEW List of drugs not recommended for use outside of clinical trials continues to grow The Disease-Modifying Treatment and Chemoprophylaxis Panel has reviewed new trial results for...
Communique

COVERAGE: COVID ‘long-haulers’, A/Prof Elliott on Saturday AM

26 September, 2020
Our Executive Director, A/Prof Julian Elliott joined Linda Mottram on ABC Radio's Saturday AM program to discuss the importance of recognising prolonged symptoms after the acute phase of...
News

Weekly Communique # 24

24 September, 2020
WEEK IN REVIEW Six-month milestone for the Taskforce There was great anxiety among clinicians back in March, as Australia prepared to face the first wave of the COVID-19 pandemic and the...
Communique

Navigating COVID-19 ‘tiger country’

22 September, 2020
In the first of a new series profiling Taskforce members, we catch up with Professor Josh Davis. An Infectious Diseases physician at Newcastle’s John Hunter Hospital and researcher...
News

Weekly Communique # 23

17 September, 2020
WEEK IN REVIEW New recommendations on VTE prophylaxis for pregnant and postpartum women The Pregnancy and Perinatal Care Panel together with the Expert Advisory Group have developed four new consensus...
Communique

What happens if I get COVID-19?

15 September, 2020
Finding trusted answers amid the widespread coverage of questionable claims and dubious data on unproven treatments is not easy. The good news is there are clear guidelines and...
Explainer

Weekly Communique # 22

11 September, 2020
WEEK IN REVIEW Commonwealth announces new ICEG/Taskforce partnership Commonwealth Minister for Health, the Hon Greg Hunt MP, this week announced the establishment of a new partnership between the Infection...
Communique

New palliative care flowchart

10 September, 2020
The Care of Older People and Palliative Care Panel has published a clinical flowchart for the Management of people with COVID-19 who are receiving palliative care. Co-Chair of the...
News

Commonwealth announces new ICEG/Taskforce partnership

9 September, 2020
Commonwealth Minister for Health, the Hon Greg Hunt MP, this week announced the establishment of a new partnership between the Infection Control Expert Group (ICEG) and the Taskforce as...
News

New evidence of life-saving benefit of corticosteroids in critically ill people with COVID-19

3 September, 2020
A landmark meta-analysis conducted for the World Health Organisation was published in JAMA this week, reporting that corticosteroid use improves survival in critically ill patients with COVID-19. The analysis pooled...
News

Weekly Communique # 21

3 September, 2020
WEEK IN REVIEW New recommendations for children and adolescents, and pregnant women The Paediatric and Adolescent Care Panel have developed two new consensus recommendations for respiratory support covering...
Communique

Weekly Communique # 20

27 August, 2020
WEEK IN REVIEW The Care of Older People and Palliative Care Panel has published a clinical flowchart for the Management of people with COVID-19 who are older and living...
Communique

Landmark publication of COVID-19 Core Outcomes Set

26 August, 2020
Our congratulations to Taskforce colleagues Professor Allison Tong and the COVID-19-Core Outcomes Set (COS) Workshop Investigators on publication of their landmark work in Critical Care Medicine. The paper reports...
News

Taskforce contribution commended by Victorian Government

25 August, 2020
Victorian Premier Daniel Andrews this week highlighted the state's support for the work of world-leading medical researchers, making significant strides in the battle against Coronavirus. Taskforce Executive Director, A/Prof Julian Elliott...
Video

Weekly Communique # 19

20 August, 2020
WEEK IN REVIEW New recommendations for Child and Adolescent Care It has been a busy week for the Child and Adolescent Care Panel with two new consensus recommendations...
Communique

Weekly Communique # 18

13 August, 2020
WEEK IN REVIEW New pregnancy and perinatal care recommendation: Skin-to-skin contact This week the Pregnancy and Perinatal Care Panel made a consensus recommendation on skin-to-skin contact between parent...
Communique

Weekly Communique # 17

6 August, 2020
WEEK IN REVIEW 'Do not use': The Taskforce has strengthened its recommendation against the use of hydroxychloroquine as a treatment for COVID-19 This week the Taskforce upgraded the strength...
Communique

Coverage: Taskforce hydroxychloroquine recommendation

5 August, 2020
Science reporter for the The Age and Sydney Morning Herald, Liam Mannix spoke to Taskforce Executive Director, A/Prof Julian Elliott regarding the 'Do Not Use' recommendation for the...
News

Weekly Communique # 16

30 July, 2020
Dear colleagues, On behalf of all members of the Taskforce, we would like to take this opportunity to acknowledge our Victorian colleagues caring for people with COVID-19 during...
Communique

Weekly Communique # 15

23 July, 2020
WEEK IN REVIEW Rooming-in recommendation The Pregnancy and Perinatal Care Panel have made their third conditional recommendation. This week's concerns Rooming-in: For women with COVID-19 who have given birth,...
Communique

Pregnancy and perinatal care guideline recommendations

23 July, 2020
This week Professor Caroline Homer AO, Co-Chair of the Pregnancy and Perinatal Care Panel, explains the recent guideline recommendations which cover: Mode of birth Breastfeeding Rooming-in
Video

Weekly Communique # 14

16 July, 2020
WEEK IN REVIEW This week we experienced a shift in the level of alert among the clinicians who form Australia's frontline healthcare response to COVID-19, particularly in Victoria....
Communique

Weekly Communique # 13

9 July, 2020
WEEK IN REVIEW COVID-19 and breastfeeding Following last week's recommendation on mode of birth, the Taskforce has now made a conditional recommendation on breastfeeding. Breastfeeding is supported irrespective of...
Communique

Taskforce makes recommendation for use of dexamethasone for patients receiving oxygen

3 July, 2020
The National COVID-19 Clinical Evidence Taskforce today gave a conditional recommendation for use of dexamethasone for the treatment of people with COVID-19 who are receiving oxygen or mechanical ventilation. The...
Media Release

Weekly Communique # 12

2 July, 2020
WEEK IN REVIEW Taskforce makes first recommendation on Dexamethasone The Taskforce has made two conditional recommendations on the use of dexamethasone in treatment of patients with COVID-19: Consider...
Communique

Weekly Communique # 11

25 June, 2020
WEEK IN REVIEW Dexamethasone now under review by the Taskforce Following Tuesday's (23 June) pre-print release of results of the dexamethesaone arm of the UK's RECOVERY study, the...
Communique

Weekly Communique # 10

18 June, 2020
WEEK IN REVIEW Dexamethasone and RECOVERY Trial  Oxford University's media release detailing preliminary results from the dexamethasone arm of the RECOVERY Trial dominated international headlines. In response, the...
Communique

Statement from the National COVID-19 Clinical Evidence Taskforce on media release of results of dexamethasone arm of the UK RECOVERY Trial

17 June, 2020
The National COVID-19 Clinical Evidence Taskforce (the Taskforce) has noted the media release of preliminary results from the dexamethasone arm of the RECOVERY (Randomised Evaluation of COVid-19 thERapY)...
Media Release

Weekly Communique # 9

11 June, 2020
WEEK IN REVIEW Time to acknowledge our expert volunteer contributions It's hard to believe that it's been 12 weeks since the Taskforce's first panel meeting. What began with...
Communique

Taskforce issues first recommendation for drug treatment for COVID-19

5 June, 2020
The National COVID-19 Clinical Evidence Taskforce today gave a conditional recommendation for use of remdesivir in treatment of people with COVID-19. The Taskforce is comprised of 28 peak health...
Media Release

Weekly Communique # 8

4 June, 2020
WEEK IN REVIEW Taskforce issues first conditional recommendation for use of an antiviral treatment for COVID-19 This week, the Taskforce has issued a conditional recommendation on the use of remdesivir: "Whenever possible...
Communique

Weekly Communique # 7

28 May, 2020
WEEK IN REVIEW The Taskforce has issued a consensus recommendation to consider increased-dose venous thromboembolism (VTE) prophylaxis for adults with severe to critical COVID-19. This recommendation was developed with input from thrombosis specialists on the Taskforce's...
Communique

Weekly Communique # 6

21 May, 2020
Dear Taskforce Members and Contributors, Welcome to our new look electronic communique. We hope to provide you with weekly updates in a simple and efficient format so should...
Communique

Weekly Communique # 5

14 May, 2020
TASKFORCE UPDATE This week we welcomed the Australian and New Zealand Society for Geriatric Medicine as a new member of the Taskforce. Two new expert guideline panels have...
Communique

Weekly Communique # 4

8 May, 2020
WEEK IN REVIEW We welcomed the following new members to the Taskforce: Australian College of Midwives Key new topics of discussion across the panels this week included: Publication...
Communique

Weekly Communique # 3

30 April, 2020
WEEK IN REVIEW We welcomed the following new members to the Taskforce: College for Emergency Nursing Australasia (CENA) Royal Australian and New Zealand College of Obstetrics and Gynaecology...
Communique

Weekly Communique # 2

23 April, 2020
WEEK IN REVIEW The Consumers Health Forum (CHF) is an official community partner of the Taskforce. We met this week to develop a consumer engagement strategy; two consumer...
Communique

Weekly Communique # 1

16 April, 2020
In the midst of another whirlwind week for all of us, it has been encouraging to see the substantial progress of the Taskforce, and also to feel an...
Communique